A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

Overview of attention for article published in Haemophilia, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 59 Mendeley

So far, Altmetric has seen 7 policy documents that reference this research output.

Evaluation of anti-factor VIII antibody levels in patients with haemophilia A receiving immune tolerance induction therapy or bypassing agents

Cited by Centers for Disease Control and Prevention (CDC) on 12 Apr 2021

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

2019 NCBDDD data for action making a difference across the lifespan : NCBDDD celebrating 20 years

Cited by Centers for Disease Control and Prevention (CDC) on 20 Jan 2021

Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, September 2020 / Vol. 69 / No. SS-5

Cited by Centers for Disease Control and Prevention (CDC) on 04 Sep 2020

Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels

Cited by Centers for Disease Control and Prevention (CDC) on 03 Aug 2018

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity, including 3 additional policy documents.